Organisation paid for research Program year 2025 Source: CMS Open Payments

Wolfe Clinic PC

Neither a doctor nor a teaching hospital

Research payments

$1,926,103

251 payments

Through program year 2025, Wolfe Clinic PC is reported as receiving $1,926,103 in research payments, across 251 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$362,660	28
2024	Research	$290,317	116
2023	Research	$624,769	63
2022	Research	$372,840	42
2021	Research	$5,517	1
2020	Research	$270,000	1

Breakdown

Who paid Research payments · program years 2020–2025

Alcon Research LLC $803,095 113 payments
Genentech, Inc. $739,877 126 payments
Regeneron Pharmaceuticals, Inc. $270,000 1 payment
Novartis Pharmaceuticals Corporation $40,428 3 payments
AbbVie, Inc. $32,346 3 payments
Alexion Pharmaceuticals, Inc. $26,557 4 payments
F. Hoffmann-La Roche AG $13,800 1 payment

Studies the money was for Research payments · program years 2020–2025

High Dose Therapy with Intravitreal Aflibercept Injection in Patients with Neovascular AMD and Diabetic Macular Edema $270,000 1 payment
Cataract Surgery Patient Comfort: Physiologic IOP with Unity CS/VCS $204,328 2 payments
Port Delivery System of Ranibizumab Extension Study $201,387 32 payments
Less Discomfort and Less pharmacology: Cataract Surgery at Physiologic IOP $176,825 3 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $169,578 20 payments
Physiologic Phacofluidics: Ghost Protocol $150,992 3 payments
Phacoemulcification at High IOP and Physiologic IOP: Impact on Anterior Segment and Posterior Segment Physiology $146,500 3 payments
Iamd Observational Study $128,659 28 payments
Phase 2 of Ro7171009 in Ga $94,522 21 payments
Next Generation Cataract Surgery Study $94,285 94 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.